ARTICLE | Clinical News
Sorafenib regulatory update
May 9, 2005 7:00 AM UTC
The partners announced acceptance of sorafenib into FDA's Pilot 1 Program for Continuous Marketing Applications (CMA). The program allows for rolling submissions of NDAs with Fast Track designation an...